Publications by authors named "J Genolla"
Purpose: To study the dependency of the effective half-life on the administered activity and the correlation between the time-integrated activity and the remnant uptake at 2d and 7d in patients treated for DTC with 1.11 GBq, 3.7 GBq or 5.
View Article and Find Full Text PDFPurpose: To analyse the activity uptakes, effective half-lives and time-integrated activities, of relevance for remnant dosimetry, for patients treated for papillary thyroid cancer (PTC) with a different amount of activity of I-NaI.
Methods: Fifty patients were included. Of those, 18 patients had low-risk PTC and were treated with 1.
Purpose: Patients with high-risk neuroblastoma have an increased risk of recurrence and relapse of disease and a very poor prognosis. I-metaiodobenzylguanidine (I-mIBG) in combination with topotecan as a radiosensitizer can be an effective and relatively well-tolerated agent for the treatment of refractory neuroblastoma. The aim of this retrospective study was to evaluate response and outcome of combined therapy with I-mIBG and topotecan.
View Article and Find Full Text PDFPurpose: To investigate the possible differences between SPECT/CT based whole-remnant and maximum-voxel dosimetry in patients receiving radio-iodine ablation treatment of differentiated thyroid cancer (DTC).
Methods: Eighteen DTC patients were administered 1.11 GBq of I-NaI after near-total thyroidectomy and rhTSH stimulation.
Purpose: To investigate the possible differences between SPECT/CT based whole-remnant and maximum-voxel dosimetry in patients receiving radio-iodine ablation treatment of differentiated thyroid cancer (DTC).
Methods: Eighteen DTC patients were administered 1.11 GBq of I-NaI after near-total thyroidectomy and rhTSH stimulation.